Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.
about
Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.Identification and mutagenesis of the adeno-associated virus 5 sialic acid binding region.Aerosol-mediated delivery of AAV2/6-IκBα attenuates lipopolysaccharide-induced acute lung injury in rats.Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors.
P2860
Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@ast
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@en
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@nl
type
label
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@ast
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@en
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@nl
prefLabel
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@ast
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@en
Bronchoalveolar fluid is not a ...... ne therapy in cystic fibrosis.
@nl
P2093
P2860
P1433
P1476
Bronchoalveolar fluid is not a ...... ene therapy in cystic fibrosis
@en
P2093
C P Rooney
D M Flaherty
G M Denning
J A Chiorini
P2860
P304
10437-10443
P356
10.1128/JVI.76.20.10437-10443.2002
P407
P577
2002-10-01T00:00:00Z